Literature DB >> 14689204

Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease.

Berta Puig1, Francesc Vinals, Isidre Ferrer.   

Abstract

Abnormal tau hyperphosphorylation and deposition in Pick bodies is a major abnormality in Pick's disease (PiD). This is associated with increased expression of the stress-activated protein kinase, p38 kinase, which has the capacity to phosphorylate tau in vitro. The present study has shown increased expression of phosphorylated p38 (p38-P), which does not cross-react with phospho-tau, in sarcosyl-insoluble fractions enriched in abnormal filaments, and hyperphosphorylated tau in the brain of two PiD cases obtained and processed with very short (less than 2 h) post-mortem delay. Immunohistochemical studies have shown p38-P co-localization in 90% of neurons with Pick bodies, whereas no positive cells are encountered in control brains processed in parallel. Moreover, p38-immunoprecipitated from sarcosyl-insoluble fractions in PiD brains is functionally active as it has the capacity to phosphorylate its specific substrate ATF-2. Combined biochemical, immunohistochemical and functional studies indicate that active p38 kinase is expressed in a very high percentage of Pick bodies, thus suggesting a critical role of this kinase in enhancing and perpetuating tau hyperphosphorylation in PiD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689204     DOI: 10.1007/s00401-003-0793-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.

Authors:  I Ferrer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Sequential abundant ion fragmentation analysis (SAIFA): an alternative approach for phosphopeptide identification using an ion trap mass spectrometer.

Authors:  Marla Chesnik; Brian Halligan; Michael Olivier; Shama P Mirza
Journal:  Anal Biochem       Date:  2011-07-30       Impact factor: 3.365

3.  Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis".

Authors:  Elisabet Aliagas; Izaskun Villar-Menéndez; Jean Sévigny; Mercedes Roca; Miriam Romeu; Isidre Ferrer; Mireia Martín-Satué; Marta Barrachina
Journal:  Purinergic Signal       Date:  2013-06-16       Impact factor: 3.765

4.  Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Hum Mol Genet       Date:  2011-09-23       Impact factor: 6.150

5.  Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.

Authors:  Mercedes Lachén-Montes; Andrea González-Morales; María Victoria Zelaya; Estela Pérez-Valderrama; Karina Ausín; Isidro Ferrer; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  Sisyphus in Neverland.

Authors:  Isidro Ferrer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies.

Authors:  Isidro Ferrer; Meritxell Aguiló García; Margarita Carmona; Pol Andrés-Benito; Benjamin Torrejón-Escribano; Paula Garcia-Esparcia; José Antonio Del Rio
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

Review 8.  Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease.

Authors:  Yasuko Kitagishi; Atsuko Nakanishi; Yasunori Ogura; Satoru Matsuda
Journal:  Alzheimers Res Ther       Date:  2014-06-20       Impact factor: 6.982

9.  Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Maria Victoria Zelaya; Maria Elena Erro Aguirre; Margarita Carmona; Karina Ausín; Mercedes Lachén-Montes; Joaquín Fernández-Irigoyen; Enrique Santamaría; José Antonio Del Rio
Journal:  Acta Neuropathol       Date:  2020-01-06       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.